Back to search
FDAFDA · Food and drugs·Recall number D-1702-2012

Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05

Published October 3, 2012 · Recall initiated: July 27, 2012

Summary

FDA records drug Class II recall D-1702-2012, published October 3, 2012 and initiated July 27, 2012. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 960 bottles; Lot: Lot ZLMM12063, Exp March 2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.

What to do

Voluntary: Firm initiated · Letter

Get an email if LEVETIRACETAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LEVETIRACETAM
Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
The product was distributed to KY.
Lot
Lot ZLMM12063, Exp March 2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05 recalled?

Yes. FDA published recall D-1702-2012 on October 3, 2012. Reported hazard: Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LEVETIRACETAM.